What are the latest figures on the fibrin sealants market’s size and projected CAGR?
The fibrin sealants market size has grown strongly in recent years. It will grow from $1.08 $ billion in 2024 to $1.17 $ billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to growth in medical tourism, growth in healthcare infrastructure, rise in elective surgical procedures, increasing prevalence of chronic diseases, and rise in demand for rapid hemostasis solutions.
The fibrin sealants market size is expected to see strong growth in the next few years. It will grow to $1.61 $ billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing number of cosmetic surgeries, increasing geriatric population, increasing number of CABG, increasing blood-related disorders, and rising number of dental surgeries. Major trends in the forecast period include technological advancements, advanced hemostatic technologies, personalized medicine, digital health technologies, and robotic-assisted surgeries.
Get Your Free Sample of The Global Fibrin Sealants Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19434&type=smp
Which Market drivers have played a significant role in driving the fibrin sealants market?
The increasing number of cosmetic surgeries is expected to propel the growth of the fibrin sealants market going forward. Cosmetic surgeries refer to medical procedures that are primarily focused on enhancing or altering a person’s appearance. Cosmetic surgeries are rising due to societal emphasis on appearance, advancements in surgical techniques, and the growing accessibility of minimally invasive procedures. Fibrin sealants help in cosmetic surgeries, promote faster wound healing, reduce bleeding, and minimize scarring, enhancing surgical outcomes and patient recovery. For instance, in September 2023, according to CosmetAssure, a US-based American Society of Plastic Surgeons, liposuction remained the most in-demand plastic surgery procedure in 2023, with 347,782 procedures performed, a 7% increase from 2022, and tummy tucks also saw a 5% rise, with 170,110 procedures performed. Therefore, the increasing number of cosmetic surgeries drives the fibrin sealants market.
What are the key segments within the fibrin sealants market?
The fibrin sealantsmarket covered in this report is segmented –
1) By Type: Liquid, Patch, Powder
2) By Technology: Autologous Donation, Viral Inactivation, Recombinant Production, Other Technologies
3) By Application: General Surgery, Cardiovascular Surgery, Wound Management, Orthopedic Surgery, Urological Surgeries, Ophthalmic Surgeries, Transplant Surgery, Other Applications
4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Liquid: Bovine-Derived Liquid Sealants, Human-Derived Liquid Sealants, Synthetic Liquid Sealants, Recombinant Fibrin Sealants
2) By Patch: Bovine-Derived Fibrin Patches, Human-Derived Fibrin Patches, Synthetic Fibrin Patches, Bioabsorbable Fibrin Patches
3) By Powder: Bovine-Derived Fibrin Powder, Human-Derived Fibrin Powder, Synthetic Fibrin Powder, Recombinant Fibrin Powder
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/fibrin-sealants-global-market-report
Which key players are shaping the fibrin sealants market?
Major companies operating in the fibrin sealants market are Johnson & Johnson, Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co. Ltd., Baxter International Inc., CSL Behring, Grifols S.A., Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd., Cohesion Technologies Inc.
Which transformative trends will shape the fibrin sealants market landscape?
Major companies operating in the fibrin sealants market are developing hemostatic agents to stop bleeding rapidly upon contact. Hemostatic agents refer to a substance or material used to stop bleeding by promoting blood clotting at a wound or surgical incision site. For instance, in February 2022, Swasth Kare, an India-based hemostatic agent manufacturer, launched SeraSeal from Wortham Laboratories, an India-based company developing hemostatic wound healing and coagulation products. SeraSeal is a fibrin sealant, designed to stop bleeding on contact, achieving hemostasis within seconds, even for arterial hemorrhages. This rapid action can be crucial in emergencies where every second counts. The translucent nature of SeraSeal allows surgeons to visualize the bleeding site clearly, facilitating better decision-making during procedures.
How do regional factors impact the fibrin sealants market, and which region is the largest contributor?
North America was the largest region in the fibrin sealants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibrin sealants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Fibrin Sealants Market Report 2025 Offer?
The fibrin sealants market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Fibrin sealants, also known as fibrin glues or fibrin tissue adhesives, are specialized medical products used to promote blood clotting and tissue healing. They are composed of two main components derived from human or animal blood, fibrinogen (a protein involved in blood clot formation) and thrombin (an enzyme that converts fibrinogen into fibrin, the main substance in blood clots). Fibrin sealants are commonly used during surgeries to control bleeding, especially in delicate or hard-to-reach areas where traditional sutures or cauterization may be insufficient.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19434
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
